TECH: Summary for Techne Corporation - Yahoo! Canada Finance

MORE ON TECH

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Techne Corporation (NasdaqNM:TECH) Delayed quote data

Last Trade:	67.45 USD
Trade Time:	Nov 24
Change:	0.00 (0.00%)
Prev Close:	67.45
Open:	N/A
Bid:	N/A
Ask:	N/A
1y Target Est:	71.00

Day's Range:	N/A - N/A
52wk Range:	45.38 - 68.23
Volume:	0
Avg Vol (3m):	124,315
Market Cap:	2.51B
P/E (ttm):	30.13
EPS (ttm):	2.24
Div & Yield:	1.01 (1.50%)

1d 5d 3m 6m 1y 2y 5y max

Free Annual Reports

Add TECH to Portfolio

Download Data

HEADLINES

•	MKS Q2 profit rises 19 pct, appoints new CEO
	Reuters (Tue 9:36am)

•	Techne Corporation: Good Risk/Reward Proposition
	at Seeking Alpha (Mon, Nov 23)

•	Air Canada tests in-flight Internet service
	Reuters (Fri, Nov 20)

•	Dell bets on corporate spending for recovery
	Reuters (Fri, Nov 20)

•	EU okays Avaya's takeover of Nortel unit
	Reuters (Thu, Nov 19)

•	Nokia Siemens, One Equity bid for some Nortel assets
	Reuters (Wed, Nov 18)

•	TSX higher as oil prices boost energy shares
	Reuters (Wed, Nov 18)

•	S&P 500 pares losses led by banks, materials
	Reuters (Wed, Nov 18)

•	Stocks fall after weak housing data
	Reuters (Wed, Nov 18)

•	Corel shares jump after Vector raises offer
	Reuters (Thu, Nov 12)

•	HP to buy 3Com for $3.1 billion
	Reuters (Thu, Nov 12)

More Headlines for TECH...

ANALYST

EPS Est (next year) (Jun-08) :	2.49
EPS Est (in 2 years) (Jun-09) :	2.74
Avg Rec (current)*:	2.3
PEG Ratio:	2.06

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

TECHNE Corporation develops and manufactures biotechnology products and hematology calibrators and controls. The company offers biotechnology products that include cytokines, which are extracted from natural sources or produced using recombinant D...

Full Company Profile

Add to Portfolio

Email to a Friend

•

	Sign In [New User? Sign Up]	Finance Home \|Help

Techne Corp. (TECH)